Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.1710
-0.0370 (-17.79%)
Feb 5, 2026, 4:00 PM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $790.16 thousand as of February 6, 2026. Its market cap has decreased by -79.38% in one year.
Market Cap
790.16K
Enterprise Value
-801.53K
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.17
Market Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 790.16K, a decrease of -97.08%. That is a compound annual growth rate of -67.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 961.37K | 15.58% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CERo Therapeutics Holdings | 1.21M |
| Sigyn Therapeutics | 1.20M |
| Halberd | 1.19M |
| Evofem Biosciences | 1.14M |
| International Stem Cell | 1.12M |
| Emmaus Life Sciences | 975.62K |
| Protagenic Therapeutics | 940.81K |
| Aibotics | 922.44K |